Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to bridge this gap may be for industry, academia, and government to develop partnerships that ...
share resources while distributing risk. However, intellectual property protections and other barriers can inhibit collaborative efforts. The Institute of Medicine held a workshop on July 22, 2010, to explore these issues and develop solutions.
Ti piace Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Drug Development? Iscriviti ad aNobii per vedere chi dei tuoi amici lo ha letto, e scopri libri simili!